Physician
Chesek, Lorraine
Chesek, Lorraine was paid $861K by Medicaid between Jun 2019 and Dec 2024, across 12 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.
33Billing provider infoCHESEK, LORRAINE
NATRONA HEIGHTS, PA 15065
NATRONA HEIGHTS, PA 15065
33aNPI1861495038assigned 05/23/2005
33bProvider typePediatrics Physician
28Total paid$861K
24GClaims18,909
24DCodes billed12
24AFirst – last monthJun 2019 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Pennsylvania
Rank by total paid#118 of 1,257
Median peer was paid$45K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 87 | $4K | |
| 2020 | 497 | $28K | |
| 2021 | 2,162 | $109K | |
| 2022 | 3,998 | $181K | |
| 2023 | 5,907 | $261K | |
| 2024incomplete | 6,258 | $278K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 3,310 | 3,251 | $260K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 4,191 | 4,100 | $211K |
| 99051 | 22% | 6,715 | 6,547 | $188K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 9.7% | 882 | 873 | $84K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.3% | 334 | 331 | $46K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.1% | 703 | 700 | $27K |
| 87428 | 1.8% | 563 | 561 | $16K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.6% | 1,141 | 569 | $14K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.6% | 916 | 906 | $13K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 62 | 61 | $2K |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 33 | 32 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 59 | 57 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.